Literature DB >> 23512657

Structural basis of protein complex formation and reconfiguration by polyglutamine disease protein Ataxin-1 and Capicua.

Eunji Kim1, Hsiang-Chih Lu, Huda Y Zoghbi, Ji-Joon Song.   

Abstract

Spinocerebellar ataxia type 1 (SCA1) is a dominantly inherited neurodegenerative disease caused by polyglutamine expansion in Ataxin-1 (ATXN1). ATXN1 binds to the transcriptional repressor Capicua (CIC), and the interaction plays a critical role in SCA1 pathogenesis whereby reducing CIC levels rescues SCA1-like phenotypes in a mouse model. The ATXN1/HBP1 (AXH) domain of ATXN1 mediates its homodimerization as well as the interaction with CIC. Here, we present the crystal structure of ATXN1's AXH domain bound to CIC and show that the binding pocket of the AXH domain to CIC overlaps with the homodimerization pocket of the AXH domain. Thus, the binding to CIC disrupts the homodimerization of ATXN1. Furthermore, the binding of CIC reconfigures the complex to allow another form of dimerization mediated by CIC, showing the intricacy of protein complex formation and reconfiguration by ATXN1 and CIC. Identifying the surfaces mediating the interactions between CIC and ATXN1 reveals a critical role for CIC in the reconfiguration of the AXH dimers and might provide insight into ways to target the ATXN1/CIC interactions to modulate SCA1 pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23512657      PMCID: PMC3613606          DOI: 10.1101/gad.212068.112

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  10 in total

1.  ATAXIN-1 interacts with the repressor Capicua in its native complex to cause SCA1 neuropathology.

Authors:  Yung C Lam; Aaron B Bowman; Paymaan Jafar-Nejad; Janghoo Lim; Ronald Richman; John D Fryer; Eric D Hyun; Lisa A Duvick; Harry T Orr; Juan Botas; Huda Y Zoghbi
Journal:  Cell       Date:  2006-12-29       Impact factor: 41.582

2.  The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins.

Authors:  Hiroshi Tsuda; Hamed Jafar-Nejad; Akash J Patel; Yaling Sun; Hung-Kai Chen; Matthew F Rose; Koen J T Venken; Juan Botas; Harry T Orr; Hugo J Bellen; Huda Y Zoghbi
Journal:  Cell       Date:  2005-08-26       Impact factor: 41.582

3.  Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals.

Authors:  A Servadio; B Koshy; D Armstrong; B Antalffy; H T Orr; H Y Zoghbi
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

4.  Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1.

Authors:  H T Orr; M Y Chung; S Banfi; T J Kwiatkowski; A Servadio; A L Beaudet; A E McCall; L A Duvick; L P Ranum; H Y Zoghbi
Journal:  Nat Genet       Date:  1993-07       Impact factor: 38.330

5.  Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1.

Authors:  Hung-Kai Chen; Pedro Fernandez-Funez; Summer F Acevedo; Yung C Lam; Michael D Kaytor; Michael H Fernandez; Alastair Aitken; Efthimios M C Skoulakis; Harry T Orr; Juan Botas; Huda Y Zoghbi
Journal:  Cell       Date:  2003-05-16       Impact factor: 41.582

6.  Identification of a self-association region within the SCA1 gene product, ataxin-1.

Authors:  E N Burright; J D Davidson; L A Duvick; B Koshy; H Y Zoghbi; H T Orr
Journal:  Hum Mol Genet       Date:  1997-04       Impact factor: 6.150

7.  The structure of the AXH domain of spinocerebellar ataxin-1.

Authors:  Yu Wai Chen; Mark D Allen; Dmitry B Veprintsev; Jan Löwe; Mark Bycroft
Journal:  J Biol Chem       Date:  2003-10-28       Impact factor: 5.157

8.  Exercise and genetic rescue of SCA1 via the transcriptional repressor Capicua.

Authors:  John D Fryer; Peng Yu; Hyojin Kang; Caleigh Mandel-Brehm; Angela N Carter; Juan Crespo-Barreto; Yan Gao; Adriano Flora; Chad Shaw; Harry T Orr; Huda Y Zoghbi
Journal:  Science       Date:  2011-11-04       Impact factor: 47.728

9.  Huntingtin facilitates polycomb repressive complex 2.

Authors:  Ihn Sik Seong; Juliana M Woda; Ji-Joon Song; Alejandro Lloret; Priyanka D Abeyrathne; Caroline J Woo; Gillian Gregory; Jong-Min Lee; Vanessa C Wheeler; Thomas Walz; Robert E Kingston; James F Gusella; Ronald A Conlon; Marcy E MacDonald
Journal:  Hum Mol Genet       Date:  2009-11-23       Impact factor: 6.150

10.  Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1.

Authors:  Janghoo Lim; Juan Crespo-Barreto; Paymaan Jafar-Nejad; Aaron B Bowman; Ronald Richman; David E Hill; Harry T Orr; Huda Y Zoghbi
Journal:  Nature       Date:  2008-03-12       Impact factor: 49.962

  10 in total
  21 in total

Review 1.  The Capicua tumor suppressor: a gatekeeper of Ras signaling in development and cancer.

Authors:  Lucía Simón-Carrasco; Gerardo Jiménez; Mariano Barbacid; Matthias Drosten
Journal:  Cell Cycle       Date:  2018       Impact factor: 4.534

2.  ATXN1-CIC Complex Is the Primary Driver of Cerebellar Pathology in Spinocerebellar Ataxia Type 1 through a Gain-of-Function Mechanism.

Authors:  Maxime W C Rousseaux; Tyler Tschumperlin; Hsiang-Chih Lu; Elizabeth P Lackey; Vitaliy V Bondar; Ying-Wooi Wan; Qiumin Tan; Carolyn J Adamski; Jillian Friedrich; Kirk Twaroski; Weili Chen; Jakub Tolar; Christine Henzler; Ajay Sharma; Aleksandar Bajić; Tao Lin; Lisa Duvick; Zhandong Liu; Roy V Sillitoe; Huda Y Zoghbi; Harry T Orr
Journal:  Neuron       Date:  2018-03-08       Impact factor: 17.173

3.  MicroRNA-136-5p protects cardiomyocytes from coronary microembolization through the inhibition of pyroptosis.

Authors:  Ruping Cai; Yuli Xu; Yanling Ren; Shirong He; Jing Zheng; Binghui Kong; Quanzhong Li; Xiheng Yang; Rixin Dai; Riming Wei; Qiang Su
Journal:  Apoptosis       Date:  2022-01-27       Impact factor: 4.677

4.  Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1.

Authors:  Ravi Chopra; David D Bushart; John P Cooper; Dhananjay Yellajoshyula; Logan M Morrison; Haoran Huang; Hillary P Handler; Luke J Man; Warunee Dansithong; Daniel R Scoles; Stefan M Pulst; Harry T Orr; Vikram G Shakkottai
Journal:  Hum Mol Genet       Date:  2020-11-25       Impact factor: 6.150

Review 5.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

6.  Cerebellar Transcriptome Profiles of ATXN1 Transgenic Mice Reveal SCA1 Disease Progression and Protection Pathways.

Authors:  Melissa Ingram; Emily A L Wozniak; Christine Henzler; Lisa Duvick; Rendong Yang; Paul Bergmann; Robert Carson; Brennon O'Callaghan; Huda Y Zoghbi; Harry T Orr
Journal:  Neuron       Date:  2016-03-03       Impact factor: 17.173

Review 7.  Pathogenic mechanisms underlying spinocerebellar ataxia type 1.

Authors:  Leon Tejwani; Janghoo Lim
Journal:  Cell Mol Life Sci       Date:  2020-04-18       Impact factor: 9.261

8.  A native interactor scaffolds and stabilizes toxic ATAXIN-1 oligomers in SCA1.

Authors:  Cristian A Lasagna-Reeves; Maxime Wc Rousseaux; Marcos J Guerrero-Muñoz; Jeehye Park; Paymaan Jafar-Nejad; Ronald Richman; Nan Lu; Urmi Sengupta; Alexandra Litvinchuk; Harry T Orr; Rakez Kayed; Huda Y Zoghbi
Journal:  Elife       Date:  2015-05-19       Impact factor: 8.140

9.  Mapping the self-association domains of ataxin-1: identification of novel non overlapping motifs.

Authors:  Rajesh P Menon; Daniel Soong; Cesira de Chiara; Mark Holt; John E McCormick; Narayana Anilkumar; Annalisa Pastore
Journal:  PeerJ       Date:  2014-03-25       Impact factor: 2.984

Review 10.  Kaleidoscopic protein-protein interactions in the life and death of ataxin-1: new strategies against protein aggregation.

Authors:  Cesira de Chiara; Annalisa Pastore
Journal:  Trends Neurosci       Date:  2014-03-11       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.